Massachusetts Financial Services Co. MA Purchases 1,884 Shares of Teleflex Incorporated (NYSE:TFX)

Massachusetts Financial Services Co. MA lifted its position in Teleflex Incorporated (NYSE:TFX) by 0.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 427,579 shares of the medical technology company’s stock after purchasing an additional 1,884 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Teleflex were worth $105,749,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Oregon Public Employees Retirement Fund increased its stake in Teleflex by 1.2% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock worth $846,000 after acquiring an additional 46 shares during the last quarter. Cromwell Holdings LLC increased its position in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after purchasing an additional 49 shares during the last quarter. Crossmark Global Holdings Inc. raised its stake in Teleflex by 1.9% in the second quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company’s stock valued at $584,000 after purchasing an additional 53 shares in the last quarter. Apollon Wealth Management LLC lifted its position in Teleflex by 3.7% during the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after purchasing an additional 55 shares during the last quarter. Finally, SRS Capital Advisors Inc. grew its stake in Teleflex by 0.3% in the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after buying an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on TFX shares. Truist Financial restated a “hold” rating and set a $227.00 price objective (down previously from $255.00) on shares of Teleflex in a research report on Monday, November 4th. Royal Bank of Canada dropped their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a research report on Wednesday. Stephens boosted their target price on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Friday, November 1st. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $259.25.

Teleflex Price Performance

Shares of Teleflex stock opened at $191.71 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a one year low of $185.66 and a one year high of $257.85. The business’s 50 day simple moving average is $224.99 and its two-hundred day simple moving average is $222.73. The stock has a market capitalization of $8.90 billion, a P/E ratio of 38.11, a price-to-earnings-growth ratio of 1.95 and a beta of 1.18.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.11. The company had revenue of $764.40 million for the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex’s quarterly revenue was up 2.4% on a year-over-year basis. During the same period last year, the firm earned $3.64 earnings per share. Analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.71%. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.